In this study, a novel injectable bone substitute (IBS) was prepared by incorporating a bioceramic powder in a polymeric solution comprising of methylcellulose (MC), gelatin and citric acid. Methylcellulose was utilized as the polymeric matrix due to its thermoresponsive properties and biocompatibility. 2.5 wt % gelatin and 3 wt % citric acid were added to the MC to adjust the rheological properties of the prepared IBS. Then, 0, 20, 30 and 50 wt % of the bioceramic component comprising tetracalcium phosphate/hydroxyapatite (TTCP/HA), dicalcium phosphate dehydrate (DCPD) and calcium sulfate dehydrate (CSD) were added into the prepared polymeric component. The prepared IBS samples had a chewing gum-like consistency. IBS samples were investiga...
Introduction: Bone diseases, aging and traumas can cause bone loss and lead to bone defects. Treatme...
A new biomaterial is presented which consists of a cellulose derivative--silanised hydroxyethylcellu...
This study investigated the in vivo performance of two composite injectable bone substitutes (IBS), ...
A major weakness of current orthopedic implant materials, for instance sintered hydroxyapatite (HA),...
The purpose of this study was to develop an injectable bone substitute (IBS) for percutaneous orthop...
International audienceInjectable bone substitutes (IBS) represent compelling options for bone regene...
International audienceThis study reports on the incorporation of the self-setting polysaccharide der...
Two formulations of biphasic injectable bone substitutes have been developed for the treatment of bo...
Despite their known osteoconductivity, clinical use of calcium phosphate cements is limited both by ...
AbstractBone repair is a multi-dimensional process that requires osteogenic cells, an osteoconductiv...
Calcium-phosphate materials have been increasingly employed in orthopedic and dental applications in...
Bone repair is a multi-dimensional process that requires osteogenic cells, an osteoconductive matrix...
Bone repair is a multi-dimensional process that requires osteogenic cells, an osteoconductive matrix...
9th European Meeting on Injectable Bone and Joint Substitution Materials, LAUSANNE, SWITZERLAND, MAR...
This work reports on the development and characterization of novel meltable polymers and composites ...
Introduction: Bone diseases, aging and traumas can cause bone loss and lead to bone defects. Treatme...
A new biomaterial is presented which consists of a cellulose derivative--silanised hydroxyethylcellu...
This study investigated the in vivo performance of two composite injectable bone substitutes (IBS), ...
A major weakness of current orthopedic implant materials, for instance sintered hydroxyapatite (HA),...
The purpose of this study was to develop an injectable bone substitute (IBS) for percutaneous orthop...
International audienceInjectable bone substitutes (IBS) represent compelling options for bone regene...
International audienceThis study reports on the incorporation of the self-setting polysaccharide der...
Two formulations of biphasic injectable bone substitutes have been developed for the treatment of bo...
Despite their known osteoconductivity, clinical use of calcium phosphate cements is limited both by ...
AbstractBone repair is a multi-dimensional process that requires osteogenic cells, an osteoconductiv...
Calcium-phosphate materials have been increasingly employed in orthopedic and dental applications in...
Bone repair is a multi-dimensional process that requires osteogenic cells, an osteoconductive matrix...
Bone repair is a multi-dimensional process that requires osteogenic cells, an osteoconductive matrix...
9th European Meeting on Injectable Bone and Joint Substitution Materials, LAUSANNE, SWITZERLAND, MAR...
This work reports on the development and characterization of novel meltable polymers and composites ...
Introduction: Bone diseases, aging and traumas can cause bone loss and lead to bone defects. Treatme...
A new biomaterial is presented which consists of a cellulose derivative--silanised hydroxyethylcellu...
This study investigated the in vivo performance of two composite injectable bone substitutes (IBS), ...